InsightfulValue
← Home

Chugai Pharmaceutical
Chugai Pharmaceutical

-14.51%

Pharma / Pharma


πŸ”§ Tools

βœ… Due Diligence
Company at a Glance

Chugai Pharmaceutical

πŸ“Š Get full analytics about Chugai Pharmaceutical

Sign up for free or log in

πŸ“– Get insights from "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" now!

Price
Live  
Infographic
Infographics
Overview
Chugai Pharmaceutical is a Japanese biopharmaceutical company that specializes in the development and manufacture of innovative medicines. It was founded in 1925 and is headquartered in Tokyo, Japan. Chugai is a subsidiary of Swiss pharmaceutical company Roche Holding AG and is a major player in the Japanese pharmaceutical market.
Chugai's primary focus is on developing treatments for cancer, renal diseases, bone and joint disorders, and autoimmune diseases. The company has a strong research and development pipeline and has received numerous approvals for its products from regulatory agencies around the world.
In addition to its research and development efforts, Chugai also has a strong commitment to corporate social responsibility and is dedicated to addressing global health issues. The company runs various programs to promote access to healthcare and provide support to underserved communities. It also has a strong sustainability strategy and is committed to reducing its environmental impact.
Chugai Pharmaceutical is a leading global biopharmaceutical company with a strong track record of success and a commitment to improving the lives of patients.
How to explain to a 10 year old kid about the company?
Chugai Pharmaceutical

πŸ“ˆ Want to read more about Chugai Pharmaceutical?

Sign up for free or log in

πŸ”“ Unlock our free guide: "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

Q2h1Z2FpIF BoYXJtYWNl dXRpY2FsIG lzIGEgY29t cGFueSB0aG F0IG1ha2Vz IG1lZGljaW 5lIHRvIGhl bHAgcGVvcG xlIGZlZWwg YmV0dGVyIH doZW4gdGhl eSBhcmUgc2 ljay4gVGhl eSBmb2N1cy BvbiBjcmVh dGluZyBzcG VjaWFsIGRy dWdzLCBlc3 BlY2lhbGx5 IGZvciBzZX Jpb3VzIGls bG5lc3Nlcy BsaWtlIGNh bmNlciBhbm QgYXV0b2lt bXVuZSBkaX NlYXNlcy4g PGJyPlRoZS B3YXkgQ2h1 Z2FpIG1ha2 VzIG1vbmV5 IGlzIGJ5IH NlbGxpbmcg dGhlc2UgbW VkaWNpbmVz IHRvIGhvc3 BpdGFscyBh bmQgZG9jdG 9ycywgd2hv IHRoZW4gZ2 l2ZSB0aGVt IHRvIHBhdG llbnRzIHdo byBuZWVkIG hlbHAuIFdo ZW4gYSBuZX cgbWVkaWNp bmUgaXMgY3 JlYXRlZCwg dGhlIGNvbX BhbnkgaGFz IHRvIGdldC BzcGVjaWFs IGFwcHJvdm FscyB0byBz ZWxsIGl0LC BhbmQgdGhp cyBwcm9jZX NzIGNhbiB0 YWtlIGEgbG 9uZyB0aW1l LiBCdXQgb2 5jZSB0aGV5 4oCZcmUgYX Bwcm92ZWQs IGlmIHRoZS BtZWRpY2lu ZSB3b3Jrcy B3ZWxsLCBt YW55IHBlb3 BsZSB3aWxs IHdhbnQgdG 8gYnV5IGl0 LCBhbmQgdG hhdOKAmXMg aG93IHRoZS Bjb21wYW55 IGVhcm5zIG 1vbmV5Ljxi cj5DaHVnYW kgaXMgc3Vj Y2Vzc2Z1bC Bmb3IgYSBm ZXcgcmVhc2 9ucy4gRmly c3QsIHRoZX kgaW52ZXN0 IGEgbG90IG 9mIG1vbmV5 IGFuZCB0aW 1lIGludG8g cmVzZWFyY2 ggdG8gZGV2 ZWxvcCBuZX cgYW5kIGJl dHRlciBtZW RpY2luZXMu IFRoaXMgYW xsb3dzIHRo ZW0gdG8gY3 JlYXRlIHVu aXF1ZSBkcn VncyB0aGF0 IGNhbiBoZW xwIHBhdGll bnRzIHdoZW 4gb3RoZXIg dHJlYXRtZW 50cyBtaWdo dCBub3Qgd2 9yay4gPGJy PlNlY29uZC wgdGhleSB3 b3JrIGNsb3 NlbHkgd2l0 aCBvdGhlci Bjb21wYW5p ZXMgYW5kIH NjaWVudGlz dHMsIGNvbW JpbmluZyB0 aGVpciBrbm 93bGVkZ2Ug YW5kIHNraW xscywgd2hp Y2ggaGVscH MgdGhlbSBj b21lIHVwIH dpdGggZXZl biBiZXR0ZX IgaWRlYXMu IDxicj5GaW 5hbGx5LCB0 aGV5IGZvY3 VzIG9uIGRp c2Vhc2VzIH RoYXQgcmVh bGx5IG5lZW QgbmV3IHRy ZWF0bWVudH MsIHNvIHRo ZXkgaGF2ZS BhIGdvb2Qg Y2hhbmNlIG 9mIG1ha2lu ZyBhIG1lZG ljaW5lIHRo YXQgcGVvcG xlIHdhbnQg YW5kIG5lZW QuIDxicj5C ZWNhdXNlIE NodWdhaSBp cyBjb21taX R0ZWQgdG8g cmVzZWFyY2 ggYW5kIGhl bHBpbmcgcG VvcGxlLCBh bmQgYmVjYX VzZSB0aGV5 IGtlZXAgYn VpbGRpbmcg c3Ryb25nIH BhcnRuZXJz aGlwcywgdG hleSBhcmUg bGlrZWx5IH RvIGNvbnRp bnVlIGJlaW 5nIHN1Y2Nl c3NmdWwgaW 4gdGhlIGZ1 dHVyZS4gTm V3IGRpc2Vh c2VzIGFuZC BoZWFsdGgg Y2hhbGxlbm dlcyB3aWxs IGFsd2F5cy Bjb21lIHVw LCBhbmQgYX MgbG9uZyBh cyB0aGV5IG tlZXAgaW5u b3ZhdGluZy BhbmQgZmlu ZGluZyBzb2 x1dGlvbnMs IHRoZXkgd2 lsbCByZW1h aW4gYW4gaW 1wb3J0YW50 IGNvbXBhbn kgaW4gdGhl IGhlYWx0aG NhcmUgZmll bGQuPGJyPg ==
What is special about the company?
Chugai Pharmaceutical

πŸ“ˆ Want to read more about Chugai Pharmaceutical?

Sign up for free or log in

⚑ Instantly access "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” free!

MS4gRm9jdX Mgb24gcmVz ZWFyY2ggYW 5kIGRldmVs b3BtZW50Oi BDaHVnYWkg aGFzIGEgc3 Ryb25nIGZv Y3VzIG9uIH Jlc2VhcmNo IGFuZCBkZX ZlbG9wbWVu dCwgd2l0aC BhIHNpZ25p ZmljYW50IH BvcnRpb24g b2YgaXRzIH JldmVudWUg YmVpbmcgaW 52ZXN0ZWQg aW4gZGV2ZW xvcGluZyBu ZXcgZHJ1Z3 MgYW5kIHRy ZWF0bWVudH MuIFRoZXkg aGF2ZSBhIG RlZGljYXRl ZCB0ZWFtIG 9mIHNjaWVu dGlzdHMgYW 5kIHJlc2Vh cmNoZXJzIG NvbnN0YW50 bHkgd29ya2 luZyB0byBk aXNjb3Zlci BuZXcgdGhl cmFwaWVzIG FuZCBpbXBy b3ZlIGV4aX N0aW5nIG9u ZXMuPGJyPj IuIElubm92 YXRpdmUgdG hlcmFwaWVz OiBDaHVnYW kgaXMga25v d24gZm9yIG l0cyBpbm5v dmF0aXZlIH RoZXJhcGll cyBpbiB0aG UgZmllbGRz IG9mIG9uY2 9sb2d5LCBp bW11bm9sb2 d5LCBhbmQg bmV1cm9zY2 llbmNlLiBU aGV5IGhhdm UgZGV2ZWxv cGVkIHNldm VyYWwgZ3Jv dW5kYnJlYW tpbmcgdHJl YXRtZW50cy wgaW5jbHVk aW5nIHRoZS B3b3JsZCdz IGZpcnN0IG dlbmV0aWMg dGVzdGluZy Bmb3IgY2Fu Y2VyIHN1c2 NlcHRpYmls aXR5IGFuZC BhIHJldm9s dXRpb25hcn kgdGFyZ2V0 ZWQgdGhlcm FweSBmb3Ig bHVuZyBjYW 5jZXIuPGJy PjMuIFBhcn RuZXJzaGlw IHdpdGggUm 9jaGU6IENo dWdhaSBoYX MgYSBzdHJh dGVnaWMgcG FydG5lcnNo aXAgd2l0aC BSb2NoZSwg b25lIG9mIH RoZSB3b3Js ZCdzIGxlYW RpbmcgcGhh cm1hY2V1dG ljYWwgY29t cGFuaWVzLi BUaGlzIHBh cnRuZXJzaG lwIGhhcyBl bmFibGVkIE NodWdhaSB0 byBhY2Nlc3 MgUm9jaGUn cyBnbG9iYW wgbmV0d29y ayBhbmQgcm Vzb3VyY2Vz LCBhbGxvd2 luZyB0aGVt IHRvIGRldm Vsb3AgYW5k IG1hcmtldC B0aGVpciBw cm9kdWN0cy BvbiBhIGds b2JhbCBzY2 FsZS48YnI+ NC4gQ29tbW l0bWVudCB0 byBwYXRpZW 50IHNhZmV0 eTogQ2h1Z2 FpIGhhcyBh IHN0cm9uZy Bjb21taXRt ZW50IHRvIH BhdGllbnQg c2FmZXR5IG FuZCBkcnVn IHF1YWxpdH kuIFRoZXkg aGF2ZSBlc3 RhYmxpc2hl ZCBhIHJvYn VzdCBwaGFy bWFjb3ZpZ2 lsYW5jZSBz eXN0ZW0gdG 8gbW9uaXRv ciB0aGUgc2 FmZXR5IGFu ZCBlZmZpY2 FjeSBvZiB0 aGVpciBwcm 9kdWN0cyBh bmQgZW5zdX JlIHRoZWly IGNvbnRpbn VvdXMgaW1w cm92ZW1lbn QuPGJyPjUu IE1hbnVmYW N0dXJpbmcg ZXhjZWxsZW 5jZTogQ2h1 Z2FpIGhhcy BzdGF0ZS1v Zi10aGUtYX J0IG1hbnVm YWN0dXJpbm cgZmFjaWxp dGllcyB0aG F0IGFkaGVy ZSB0byBzdH JpY3QgcXVh bGl0eSBjb2 50cm9sIHN0 YW5kYXJkcy 4gVGhpcyBh bGxvd3MgdG hlbSB0byBj b25zaXN0ZW 50bHkgcHJv ZHVjZSBoaW doLXF1YWxp dHkgcHJvZH VjdHMgYW5k IGVuc3VyZS B0aGUgc2Fm ZXR5IGFuZC BlZmZlY3Rp dmVuZXNzIG 9mIHRoZWly IHRyZWF0bW VudHMuPGJy PjYuIFNvY2 lhbCByZXNw b25zaWJpbG l0eTogQ2h1 Z2FpIGhhcy BhIHN0cm9u ZyBzZW5zZS BvZiBzb2Np YWwgcmVzcG 9uc2liaWxp dHksIGFuZC B0aGVpciBi dXNpbmVzcy BvcGVyYXRp b25zIGFyZS BndWlkZWQg YnkgZXRoaW NhbCBwcmlu Y2lwbGVzLi BUaGV5IGFy ZSBjb21taX R0ZWQgdG8g ZGV2ZWxvcG luZyBzdXN0 YWluYWJsZS BhbmQgZW52 aXJvbm1lbn RhbGx5IGZy aWVuZGx5IH ByYWN0aWNl cywgYW5kIH RoZXkgY29u dHJpYnV0ZS B0byB2YXJp b3VzIGluaX RpYXRpdmVz IGFuZCBjaG FyaXRpZXMg dG8gYmVuZW ZpdCBzb2Np ZXR5Ljxicj 43LiBHbG9i YWwgcHJlc2 VuY2U6IENo dWdhaSBoYX MgYSBnbG9i YWwgcHJlc2 VuY2UsIHdp dGggYnJhbm NoZXMgaW4g QXNpYSwgRX Vyb3BlLCBh bmQgdGhlIF VuaXRlZCBT dGF0ZXMuIF RoaXMgYWxs b3dzIHRoZW 0gdG8gcmVh Y2ggbWFya2 V0cyB3b3Js ZHdpZGUgYW 5kIGNvbGxh Ym9yYXRlIH dpdGggaW50 ZXJuYXRpb2 5hbCBwYXJ0 bmVycyBhbm QgcmVzZWFy Y2hlcnMsIG xlYWRpbmcg dG8gYSBtb3 JlIGRpdmVy c2UgcmFuZ2 Ugb2YgbWVk aWNhdGlvbn MgYW5kIHRy ZWF0bWVudH MuPGJyPjgu IEVtcGxveW VlLWNlbnRy aWMgY29tcG FueSBjdWx0 dXJlOiBDaH VnYWkgaGFz IGEgc3Ryb2 5nIGNvbXBh bnkgY3VsdH VyZSB0aGF0 IHZhbHVlcy BpdHMgZW1w bG95ZWVzJy Bjb250cmli dXRpb25zIG FuZCB3ZWxs LWJlaW5nLi BUaGV5IHBy b3ZpZGUgb3 Bwb3J0dW5p dGllcyBmb3 IgbGVhcm5p bmcgYW5kIG dyb3d0aCwg cHJvbW90ZS B3b3JrLWxp ZmUgYmFsYW 5jZSwgYW5k IGVuY291cm FnZSBhIGNv bGxhYm9yYX RpdmUgYW5k IGRpdmVyc2 Ugd29ya3Bs YWNlLjxicj 45LiBBd2Fy ZHMgYW5kIH JlY29nbml0 aW9uOiBDaH VnYWkgaGFz IHJlY2Vpdm VkIG51bWVy b3VzIGF3YX JkcyBhbmQg cmVjb2duaX Rpb24gZm9y IGl0cyBwZX Jmb3JtYW5j ZSBhbmQgY2 9udHJpYnV0 aW9ucyB0by B0aGUgaGVh bHRoY2FyZS BpbmR1c3Ry eS4gVGhpcy BpbmNsdWRl cyBiZWluZy ByYW5rZWQg YXMgb25lIG 9mIHRoZSB0 b3AgcGhhcm 1hY2V1dGlj YWwgY29tcG FuaWVzIGlu IEphcGFuIG FuZCByZWNl aXZpbmcgYW Njb2xhZGVz IGZvciBpdH MgY29ycG9y YXRlIHN1c3 RhaW5hYmls aXR5IGVmZm 9ydHMuPGJy PjEwLiBTdH JvbmcgZmlu YW5jaWFsIH BlcmZvcm1h bmNlOiBDaH VnYWkgaGFz IGEgdHJhY2 sgcmVjb3Jk IG9mIHN0cm 9uZyBmaW5h bmNpYWwgcG VyZm9ybWFu Y2UsIHdpdG ggY29uc2lz dGVudCBncm 93dGggYW5k IHByb2ZpdG FiaWxpdHku IFRoaXMgaG FzIGFsbG93 ZWQgdGhlbS B0byBpbnZl c3QgaW4gcm VzZWFyY2gg YW5kIGRldm Vsb3BtZW50 IGFuZCBleH BhbmQgdGhl aXIgcHJvZH VjdCBwb3J0 Zm9saW8sIG 1ha2luZyB0 aGVtIGEgZm luYW5jaWFs bHkgc3RhYm xlIGFuZCBy ZWxpYWJsZS Bjb21wYW55 Lg==
What the company's business model?
Chugai Pharmaceutical

πŸ“ˆ Want to read more about Chugai Pharmaceutical?

Sign up for free or log in

πŸ’‘ Learn smarter stock picks with "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

VGhlIENodW dhaSBQaGFy bWFjZXV0aW NhbCBjb21w YW55J3MgYn VzaW5lc3Mg bW9kZWwgaX MgYmFzZWQg b24gcmVzZW FyY2gsIGRl dmVsb3BtZW 50LCBwcm9k dWN0aW9uLC BhbmQgc2Fs ZSBvZiBwaG FybWFjZXV0 aWNhbCBwcm 9kdWN0cy4g VGhlIGNvbX BhbnkgcHJp bWFyaWx5IG ZvY3VzZXMg b24gdHJlYX RtZW50cyBm b3IgZGlzZW FzZXMgaW4g dGhlIGFyZW FzIG9mIG9u Y29sb2d5LC Bib25lIGFu ZCBqb2ludC BkaXNvcmRl cnMsIHJlbm FsIGRpc2Vh c2VzLCBhbm QgYXV0b2lt bXVuZSBkaX NlYXNlcy4g Q2h1Z2FpIG Fsc28gaGFz IGEgcHJlc2 VuY2UgaW4g ZGlhZ25vc3 RpYyByZWFn ZW50cywgbW VkaWNhbCBk ZXZpY2VzLC BhbmQgb3Zl ci10aGUtY2 91bnRlciBw cm9kdWN0cy 4gVGhlIGNv bXBhbnkgY2 9uZHVjdHMg ZXh0ZW5zaX ZlIHJlc2Vh cmNoIGFuZC BjbGluaWNh bCB0cmlhbH MgdG8gZGV2 ZWxvcCBuZX cgYW5kIGVm ZmVjdGl2ZS BkcnVncywg YW5kIHBhcn RuZXJzIHdp dGggb3RoZX IgcGhhcm1h Y2V1dGljYW wgY29tcGFu aWVzIGZvci Bjby1kZXZl bG9wbWVudC BhbmQgY28t bWFya2V0aW 5nIG9wcG9y dHVuaXRpZX MuIENodWdh aSdzIGJ1c2 luZXNzIG1v ZGVsIGFsc2 8gaW5jbHVk ZXMgcGFydG 5lcnNoaXBz IGFuZCBjb2 xsYWJvcmF0 aW9ucyB3aX RoIGFjYWRl bWljIGluc3 RpdHV0aW9u cyBhbmQgcm VzZWFyY2gg b3JnYW5pem F0aW9ucyB0 byBkcml2ZS Bpbm5vdmF0 aW9uIGFuZC BkcnVnIGRp c2NvdmVyeS 4gVGhlIGNv bXBhbnkgZm 9sbG93cyBh IGdsb2JhbC BleHBhbnNp b24gc3RyYX RlZ3ksIHdp dGggYSBwcm VzZW5jZSBp biBKYXBhbi wgQXNpYSwg RXVyb3BlLC BhbmQgdGhl IFVuaXRlZC BTdGF0ZXMs IGFpbWluZy B0byByZWFj aCBhIHdpZG VyIG1hcmtl dCBhbmQgaW 5jcmVhc2Ug aXRzIHJldm VudWUuIEFk ZGl0aW9uYW xseSwgQ2h1 Z2FpIGlzIG NvbW1pdHRl ZCB0byBzdX N0YWluYWJs ZSBncm93dG ggdGhyb3Vn aCByZXNwb2 5zaWJsZSBi dXNpbmVzcy BwcmFjdGlj ZXMsIGVtcG xveWVlIGRl dmVsb3BtZW 50LCBhbmQg Y29ycG9yYX RlIHNvY2lh bCByZXNwb2 5zaWJpbGl0 eSBpbml0aW F0aXZlcy4=
Is AI a threat?
AI poses potential threats to Chugai Pharmaceutical’s products, services, and competitive positioning in various ways:
1. Substitution: AI technologies can lead to the development of alternative therapies and treatments that may compete with Chugai’s existing products. For instance, advances in AI-driven drug discovery can facilitate the rapid identification of novel compounds, leading to new treatments that could replace traditional pharmaceuticals. Additionally, AI-powered personalized medicine may offer tailored solutions that could reduce the demand for some of Chugai’s standard offerings.
2. Disintermediation: AI can streamline processes in drug development, clinical trials, and patient management, which may reduce the need for certain intermediaries such as clinical research organizations or even traditional healthcare providers. This shift could impact how Chugai conducts its research and engages with healthcare stakeholders, potentially leading to a more direct relationship with patients or healthcare systems.
3. Margin Pressure: The integration of AI in healthcare can increase competition among pharmaceutical companies, as firms that effectively leverage AI may enhance operational efficiencies, reduce costs, and deliver products faster. This competitive pressure could lead to pricing challenges for Chugai, as it may need to lower its prices to maintain market share against more cost-effective alternatives developed using AI.
Overall, while AI offers opportunities for innovation and efficiency, it also presents challenges that Chugai Pharmaceutical must navigate to maintain its competitive edge.
Sensitivity to interest rates
Chugai Pharmaceutical’s earnings, cash flow, and valuation can be sensitive to changes in interest rates due to several factors:
1. Cost of Capital: Higher interest rates can increase the cost of debt for Chugai, leading to higher interest expenses. This could negatively impact net earnings as a greater portion of income is directed to servicing debt rather than reinvestment or shareholder returns.
2. Investment Decisions: Elevated interest rates can lead to a reevaluation of capital expenditures and R&D investments. If borrowing costs rise, the company might cut back on investment in new drug development or other projects, which can affect future growth and revenue streams.
3. Discount Rates: Valuation models, especially discounted cash flow (DCF) analyses, are highly sensitive to the discount rate. As interest rates increase, the discount rate applied to future cash flows rises, which can reduce the present value of those cash flows and adversely affect the company’s valuation.
4. Market Sentiment: Changes in interest rates can influence overall market sentiment towards equities. Higher rates may lead to lower stock prices as investors seek higher returns from fixed-income securities, which can affect Chugai’s market capitalization and investor perception.
5. Foreign Exchange Implications: If Chugai operates internationally, changes in interest rates could impact currency valuations, affecting revenues from overseas markets or the cost of repatriating profits.
6. Economic Environment: Higher interest rates may slow economic growth and reduce overall healthcare spending. This could impact prescription drug sales and overall demand for Chugai’s products.
Overall, while Chugai Pharmaceutical may have some inherent stability due to its established position in the pharmaceutical industry, its earnings, cash flow, and valuation would still be influenced by fluctuations in interest rates, necessitating careful monitoring and strategic responses.
Resilience to the future changes
Chugai Pharmaceutical

πŸ“ˆ Want to read more about Chugai Pharmaceutical?

Sign up for free or log in

πŸ“š Your free copy of "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" is waiting

T25lIHJlYW xpc3RpYyBz Y2VuYXJpby B0aGF0IGNv dWxkIHBlcm 1hbmVudGx5 IGltcGFpci BDaHVnYWkg UGhhcm1hY2 V1dGljYWzi gJlzIGVjb2 5vbWljcyBv dmVyIHRoZS BuZXh0IDMt NSB5ZWFycy BpcyB0aGUg c2lnbmlmaW NhbnQgbG9z cyBvZiBwYX RlbnQgcHJv dGVjdGlvbi Bmb3Igc2V2 ZXJhbCBvZi BpdHMga2V5 IGRydWdzLC Bjb21iaW5l ZCB3aXRoIG FuIGluYWJp bGl0eSB0by BzdWNjZXNz ZnVsbHkgbG F1bmNoIG5l dywgaW5ub3 ZhdGl2ZSBw cm9kdWN0cy B0byByZXBs YWNlIGxvc3 QgcmV2ZW51 ZXMuIFRoaX Mgc2l0dWF0 aW9uIGNvdW xkIGJlIGV4 YWNlcmJhdG VkIGJ5IGlu Y3JlYXNlZC Bjb21wZXRp dGlvbiBmcm 9tIGdlbmVy aWMgZHJ1Z3 MgYW5kIGJp b3NpbWlsYX JzLCByZWd1 bGF0b3J5IG NoYWxsZW5n ZXMsIG9yIH NoaWZ0cyBp biBoZWFsdG hjYXJlIHBv bGljaWVzIH RoYXQgZmF2 b3IgbG93ZX ItY29zdCBh bHRlcm5hdG l2ZXMuPGJy PklmIHRoaX Mgc2NlbmFy aW8gcGxheW VkIG91dCwg Q2h1Z2Fp4o CZcyBtYXJn aW5zIHdvdW xkIGxpa2Vs eSBzaHJpbm sgc2lnbmlm aWNhbnRseS 4gV2l0aCB0 aGUgbG9zcy BvZiBwYXRl bnQgcHJvdG VjdGlvbiwg dGhlIGNvbX Bhbnkgd291 bGQgZXhwZX JpZW5jZSBh IHNoYXJwIG RlY2xpbmUg aW4gcHJpY2 luZyBwb3dl ciBmb3IgaX RzIGxlYWRp bmcgcHJvZH VjdHMsIGxl YWRpbmcgdG 8gcmVkdWNl ZCByZXZlbn VlLiBBcyBs b3dlci1jb3 N0IGdlbmVy aWNzIGFuZC BiaW9zaW1p bGFycyBlbn RlciB0aGUg bWFya2V0LC B0aGlzIGNv dWxkIGZ1cn RoZXIgZXJv ZGUgc2FsZX MuIFRoZSBj b21wYW55IG 1pZ2h0IGZp bmQgaXRzZW xmIGZvcmNl ZCB0byBjdX QgcHJpY2Vz IHRvIG1haW 50YWluIG1h cmtldCBzaG FyZSwgcmVz dWx0aW5nIG luIHNxdWVl emVkIHByb2 ZpdCBtYXJn aW5zLjxicj 5DYXNoIGZs b3cgd291bG QgYWxzbyBi ZSBuZWdhdG l2ZWx5IGFm ZmVjdGVkLi BUaGUgZGVj bGluZSBpbi ByZXZlbnVl IGZyb20ga2 V5IHByb2R1 Y3RzIHdvdW xkIHJlZHVj ZSBvcGVyYX Rpb25hbCBj YXNoIGZsb3 dzLCBtYWtp bmcgaXQgbW 9yZSBjaGFs bGVuZ2luZy Bmb3IgQ2h1 Z2FpIHRvIG ludmVzdCBp biByZXNlYX JjaCBhbmQg ZGV2ZWxvcG 1lbnQgZm9y IG5ldyBkcn Vncy4gVGhl IGNvbXBhbn kgbWlnaHQg bmVlZCB0by ByZWRpcmVj dCBmdW5kcy Bhd2F5IGZy b20gZ3Jvd3 RoIHByb2pl Y3RzIHRvIG NvdmVyIG9u Z29pbmcgb3 BlcmF0aW9u YWwgY29zdH MsIGNyZWF0 aW5nIGEgdm ljaW91cyBj eWNsZSBvZi BkZWNsaW5p bmcgaW5ub3 ZhdGlvbiBh bmQgY29tcG V0aXRpdmVu ZXNzLjxicj 5BZGRpdGlv bmFsbHksIH RoZSBiYWxh bmNlIHNoZW V0IGNvdWxk IHN1ZmZlci BhcyBhIHJl c3VsdCBvZi BkZWNsaW5p bmcgcmV2ZW 51ZXMuIExv d2VyIGNhc2 ggZmxvd3Mg bWlnaHQgbG VhZCB0byBh IGxpcXVpZG l0eSBjcnVu Y2gsIGFuZC BDaHVnYWkg Y291bGQgZm luZCBpdCBu ZWNlc3Nhcn kgdG8gdGFr ZSBvbiBkZW J0IHRvIHN1 c3RhaW4gb3 BlcmF0aW9u cyBvciBpbn Zlc3QgaW4g bmV3IGFyZW FzLiBJZiB0 aGUgY29tcG FueSBkZWNp ZGVzIHRvIH B1cnN1ZSBt ZXJnZXJzIG 9yIGFjcXVp c2l0aW9ucy B0byBib2xz dGVyIGl0cy BwaXBlbGlu ZSwgdGhpcy Bjb3VsZCBm dXJ0aGVyIG luY3JlYXNl IGl0cyBsZX ZlcmFnZS4g Q29uc2VxdW VudGx5LCBm aW5hbmNpYW wgcmF0aW9z IHN1Y2ggYX MgZGVidC10 by1lcXVpdH kgd291bGQg d29yc2VuLC ByZWZsZWN0 aW5nIGhlaW dodGVuZWQg cmlzayBhbm QgcG9zc2li bHkgbGVhZG luZyB0byBo aWdoZXIgYm 9ycm93aW5n IGNvc3RzIG 9yIGEgZG93 bmdyYWRlIG luIGNyZWRp dCByYXRpbm dzLjxicj5J biBzdW1tYX J5LCB0aGUg Y29tYmluYX Rpb24gb2Yg bG9zaW5nIH BhdGVudCBw cm90ZWN0aW 9uIGZvciBr ZXkgcHJvZH VjdHMsIGlu Y3JlYXNlZC Bjb21wZXRp dGlvbiwgYW 5kIGFuIGlu YWJpbGl0eS B0byBpbm5v dmF0ZSB3b3 VsZCBncmVh dGx5IGltcG FpciBDaHVn YWkgUGhhcm 1hY2V1dGlj YWzigJlzIG Vjb25vbWlj cywgbGVhZG luZyB0byBz aWduaWZpY2 FudGx5IGxv d2VyIG1hcm dpbnMsIHN0 cmFpbmVkIG Nhc2ggZmxv dywgYW5kIG Egd2Vha2Vu ZWQgYmFsYW 5jZSBzaGVl dCBvdmVyIH RoZSBuZXh0 IGZldyB5ZW Fycy48YnI+
Interesting facts about the company
Chugai Pharmaceutical

πŸ“ˆ Want to read more about Chugai Pharmaceutical?

Sign up for free or log in

πŸ”“ Unlock our free guide: "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3Mvbj R6ZGQ2RHNh MkFqSUVmNj FaTWQud2Vi cCIgYWx0PS JDaHVnYWkg UGhhcm1hY2 V1dGljYWwi IHRpdGxlPS JDaHVnYWkg UGhhcm1hY2 V1dGljYWwi ICBjbGFzcz 0iaW1nLWZs dWlkIiBoZW lnaHQ9NTAg d2lkdGg9NT AgbG9hZGlu Zz0nbGF6eS cgc3R5bGU9 J2JvcmRlci 1yYWRpdXM6 IDZweDsnPg oKICAgICAg ICAgICAgIC AgICAgICA8 ZGl2IHN0eW xlPSdmbGV4 OiAxOyB0ZX h0LWFsaWdu OiBjZW50ZX I7IG1hcmdp bi1sZWZ0Oi A1cHg7Jz4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgPHAgc3R5 bGU9J2Zvbn Qtc2l6ZTog MjZweDsgY2 9sb3I6ICMz MzM7IG1hcm dpbi1ib3R0 b206IDE1cH g7Jz4KICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIPCfk4gg V2FudCB0by ByZWFkIG1v cmUgYWJvdX QgQ2h1Z2Fp IFBoYXJtYW NldXRpY2Fs PwogICAgIC AgICAgICAg ICAgICAgIC AgICA8L3A+ CgogICAgIC AgICAgICAg ICAgICAgIC AgICA8YSBo cmVmPSdpbm RleC5waHA/ cGFnZT1zaW dudXAnIHN0 eWxlPScKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGJhY2 tncm91bmQt Y29sb3I6IC MwMDdCRkY7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBj b2xvcjogI2 ZmZjsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH ggMjBweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIGJv cmRlci1yYW RpdXM6IDVw eDsKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IHRleHQtZG Vjb3JhdGlv bjogbm9uZT sKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG ZvbnQtd2Vp Z2h0OiBib2 xkOwogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgbWFyZ2lu LXJpZ2h0Oi AxMHB4Owog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgdHJh bnNpdGlvbj ogYmFja2dy b3VuZC1jb2 xvciAwLjNz IGVhc2U7Jw ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgb2 5tb3VzZW92 ZXI9J3RoaX Muc3R5bGUu YmFja2dyb3 VuZENvbG9y PSIjMDA1Nm IzIicKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIG9ubW91 c2VvdXQ9J3 RoaXMuc3R5 bGUuYmFja2 dyb3VuZENv bG9yPSIjMD A3QkZGIic+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBT aWduIHVwIG ZvciBmcmVl CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDwvYT4K CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDxzcGFu IHN0eWxlPS dtYXJnaW46 IDAgOHB4Oy Bjb2xvcjog IzU1NTsnPm 9yPC9zcGFu PgoKICAgIC AgICAgICAg ICAgICAgIC AgICAgPGEg aHJlZj0naW 5kZXgucGhw P3BhZ2U9bG 9naW4nIHN0 eWxlPScKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGNvbG 9yOiAjMDA3 QkZGOwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgdGV4dC 1kZWNvcmF0 aW9uOiB1bm RlcmxpbmU7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBm b250LXdlaW dodDogNTAw Oyc+CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICBsb2cgaW 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgPC9hPg oKCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDxwIH N0eWxlPSdt YXJnaW4tdG 9wOiAxNXB4 OyBmb250LX NpemU6IDEz cHg7IGZvbn Qtd2VpZ2h0 OiBib2xkOy Bjb2xvcjog I2QzMmYyZj snPgogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Ag8J+RpSBG cmVlIGVCb2 9rIGZvciBu ZXcgdXNlcn M6IDxpPiJU aGUgQ2hlY2 tsaXN0IFZh bHVlIEludm VzdG9yIOKA lCBBIFNtYX J0ZXIgV2F5 IHRvIFBpY2 sgU3RvY2tz IjwvaT4KIC AgICAgICAg ICAgICAgIC AgICAgICAg PC9wPgoKIC AgICAgICAg ICAgICAgIC AgICAgICAg PCEtLQogIC AgICAgICAg ICAgICAgIC AgICAgICA8 ZGl2IHN0eW xlPSdtYXJn aW4tdG9wOi AxMnB4OyBm b250LXNpem U6IDEzcHg7 IGNvbG9yOi AjNDQ0Oyc+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBT aWduIHVwIG 5vdyBhbmQg Z2V0IG91ci BmcmVlIGVC b29rIAogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgPGI+VG hlIENoZWNr bGlzdCBWYW x1ZSBJbnZl c3RvciDigJ QgQSBTbWFy dGVyIFdheS B0byBQaWNr IFN0b2Nrcz wvYj4KICAg ICAgICAgIC AgICAgICAg ICAgICAgPC 9kaXY+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC 0tPgogICAg ICAgICAgIC AgICAgICAg ICAgICA8IS 0tCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDxkaX Ygc3R5bGU9 J21hcmdpbi 10b3A6IDE2 cHg7IGZvbn Qtc2l6ZTog MTRweDsgY2 9sb3I6ICM0 NDQ7IGZvbn QtZmFtaWx5 OiAtYXBwbG Utc3lzdGVt LCBCbGlua0 1hY1N5c3Rl bUZvbnQsIF NlZ29lIFVJ LCBSb2JvdG 8sIEhlbHZl dGljYSBOZX VlLCBzYW5z LXNlcmlmOy BsaW5lLWhl aWdodDogMS 42Oyc+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBIYXZl IHlvdSBoZW FyZCBhYm91 dCBvdXIgc2 hvcnQgPHN0 cm9uZyBzdH lsZT0nZm9u dC13ZWlnaH Q6IDYwMDsn PkRhaWx5IF ZpZGVvIE5l d3NsZXR0ZX I8L3N0cm9u Zz4/CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICA8YSBocm VmPSdodHRw czovL3d3dy 5pbnNpZ2h0 ZnVsdmFsdW UuY29tL25l d3NsZXR0ZX IucGhwJyB0 YXJnZXQ9J1 9ibGFuaycg c3R5bGU9J2 NvbG9yOiAj MDA3QkZGOy B0ZXh0LWRl Y29yYXRpb2 46IG5vbmU7 IGZvbnQtd2 VpZ2h0OiA1 MDA7IG1hcm dpbi1sZWZ0 OiA2cHg7Jz 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBGaW5k IG91dCBtb3 JlCiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC A8L2E+CiAg ICAgICAgIC AgICAgICAg ICAgICAgID wvZGl2Pgog ICAgICAgIC AgICAgICAg ICAgICAgIC AtLT4KICAg ICAgICAgIC AgICAgICAg ICA8L2Rpdj 4KICAgICAg ICAgICAgIC AgIDwvZGl2 PgogICAgIC AgICAgICA8 L2Rpdj4KIC AgICAgICAg ICAgCiAgIC AgICAgCiAg ICAgICAgPH NwYW4gY2xh c3M9J2JsdX JyZWQtdGV4 dCc+CiAgIC AgICAgICAg IE1TNGdRMm gxWjIgRnBJ RkJvWVhKdC BZV05sZFhS cFkyIEZzSU dseklHRWcg U21Gd1lXNW xjMiBVZ1lt bHZjR2hoIG NtMWhZMlYx ZEcgbGpZV3 dnWTI5dCBj R0Z1ZVNCMG FHIEYwSUhk aGN5Qm0gYj NWdVpHVmtJ RyBsdUlERT VNalVnIFlY TWdRMmgxWj IgRnBJRk5v YjNSbCBiaT RnU1hRZ2FY IE1nYjI1bE lHOW0gSUhS b1pTQnZiRy BSbGMzUWdZ VzVrIElHeG hjbWRsYzMg UWdjR2hoY2 0xaCBZMlYx ZEdsallXIH dnWTI5dGNH RnUgYVdWek lHbHVJRSBw aGNHRnVMan hpIGNqNHlM aUJVYUcgVW dZMjl0Y0dG dSBlU0IzWV hNZ2NtIFZ1 WVcxbFpDQk QgYUhWbllX a2dVRyBoaG NtMWhZMlYx IGRHbGpZV3 dnUTIgOHVM Q0JNZEdRdS BJR2x1SURF NU5EIFFnWV c1a0lIZGwg Ym5RZ2NIVm liRyBsaklH bHVJREU1IE 5Ea3VQR0p5 UGogTXVJRU 5vZFdkaCBh U0JRYUdGeW JXIEZqWlhW MGFXTmggYk NCcGN5Qm9a VyBGa2NYVm hjblJsIGNt VmtJR2x1SU YgUnZhM2x2 TENCSyBZWE JoYmlCaGJt IFFnYUdGek lHOXcgWlhK aGRHbHZibi BNZ2FXNGdi Vzl5IFpTQj BhR0Z1SUQg TXdJR3h2WT JGMCBhVzl1 Y3lCM2IzIE pzWkhkcFpH VXUgUEdKeV BqUXVJRiBS b1pTQmpiMj F3IFlXNTVJ R2x6SUcgRW djM1ZpYzJs ayBhV0Z5ZV NCdlppIEJU ZDJsemN5Qn cgYUdGeWJX RmpaWCBWMG FXTmhiQ0Ju IGFXRnVkQ0 JTYjIgTm9a U3dnZDJocC BZMmdnWVdO eGRXIGx5Wl dRZ1lTQnQg WVdwdmNtbD BlUyBCemRH RnJaU0JwIG JpQkRhSFZu WVcga2dhVz RnTWpBdyBN aTQ4WW5JK0 5TIDRnUTJo MVoyRnAgSU dseklHdHVi MyBkdUlHWn ZjaUJwIGRI TWdhVzV1Yj MgWmhkR2wy WlNCdCBaV1 JwWTJGc0lI IEpsYzJWaG NtTm8gSUdG dVpDQmtaWC BabGJHOXdi V1Z1IGRDd2 dkMmwwYUMg QmhJR1p2WT NWeiBJRzl1 SUdKcGIyIH h2WjJsallX d2cgZEdobG NtRndhVyBW eklITjFZMm dnIFlYTWdZ VzUwYVcgSn ZaR2xsY3lC aCBibVFnWm 5WemFXIDl1 SUhCeWIzUm wgYVc1ekxq eGljaiA0Mk xpQlBibVVn IGIyWWdkR2 hsSUcgTnZi WEJoYm5uaS BnSmx6SUcx dmMzIFFnYm 05MFlXSnMg WlNCd2NtOW tkVyBOMGN5 QnBjeUJCIF kzUmxiWEpo TEMgQmhiaU JoYm5ScCBZ bTlrZVMxaV lYIE5sWkNC MGNtVmggZE cxbGJuUWda bSA5eUlISm 9aWFZ0IFlY UnZhV1FnWV ggSjBhSEpw ZEdseiBJR0 Z1WkNCdmRH IGhsY2lCaG RYUnYgYVcx dGRXNWxJRy BScGMyOXla R1Z5IGN5ND hZbkkrTnkg NGdRMmgxWj JGcCBJRkJv WVhKdFlXIE 5sZFhScFky RnMgSUdoaG N5QmhJSCBO MGNtOXVaeU J3IGNtVnpa VzVqWlMgQn BiaUIwYUdV ZyBRWE5wWV MxUVlXIE5w Wm1saklISm wgWjJsdmJp d2dkMiBsMG FDQmhabVpw IGJHbGhkR1 Z6SUcgRnVa Q0J3WVhKMC BibVZ5YzJo cGNIIE1nYV c0Z1kyOTEg Ym5SeWFXVn pJSCBOMVky Z2dZWE1nIF EyaHBibUVz SUYgTnZkWF JvSUV0diBj bVZoTENCaG JtIFFnU1c1 a2FXRXUgUE dKeVBqZ3VJ RiBSb1pTQm piMjF3IFlX NTVJR2hoY3 kgQmhJR3h2 Ym1jZyBhR2 x6ZEc5eWVT IEJ2WmlCam IyeHMgWVdK dmNtRjBhVy A5dUlIZHBk R2dnIFlXTm haR1Z0YVcg TWdhVzV6ZE dsMCBkWFJw YjI1eklHIE Z1WkNCdmRH aGwgY2lCd2 FHRnliVyBG alpYVjBhV0 5oIGJDQmpi MjF3WVcgNX BaWE1zSUd4 bCBZV1JwYm 1jZ2RHIDhn WjNKdmRXNW sgWW5KbFlX dHBibSBjZ1 pHbHpZMjky IFpYSnBaWE 1nWVcgNWtJ R0ZrZG1GdS BZMlZ0Wlc1 MGN5IEJwYm lCdFpXUnAg WTJGc0lIUn laVyBGMGJX VnVkSE11IF BHSnlQamt1 SUUgbHVJR0 ZrWkdsMCBh Vzl1SUhSdk lHIGwwY3lC bWIyTjEgY3 lCdmJpQndh RyBGeWJXRm paWFYwIGFX TmhiSE1zSU UgTm9kV2Ro YVNCaCBiSE 52SUc5d1pY IEpoZEdWek lHbHUgSUhS b1pTQm1iMi A5a2N5d2da bWx1IFpTQm phR1Z0YVcg TmhiSE1zSU dGdSBaQ0J0 WldScFkyIE ZzSUdWeGRX bHcgYldWdW RDQnBibSBS MWMzUnlhV1 Z6IExqeGlj ajR4TUMgNG dRMmgxWjJG cCBJRkJvWV hKdFlXIE5s ZFhScFkyRn MgSUdseklH TnZiVyAxcG RIUmxaQ0Iw IGJ5Qmxibl pwY20gOXVi V1Z1ZEdGcy BJSE4xYzNS aGFXIDVoWW 1sc2FYUjUg SUdGdVpDQm 9ZWCBNZ2FX MXdiR1Z0IF pXNTBaV1Fn WVMgQnVkVz FpWlhJZyBi MllnYVc1cG RHIGxoZEds MlpYTWcgZE c4Z2NtVmtk VyBObElHbD BjeUJqIFlY SmliMjRnWm 0gOXZkSEJ5 YVc1MCBJR0 Z1WkNCd2Nt IDl0YjNSbE lHVmogYnkx bWNtbGxibS BSc2VTQndj bUZqIGRHbG paWE11CiAg ICAgICAgPC 9zcGFuPgog ICAgICAgIA ogICAgICAg IA==
See Company Q&A
Chugai Pharmaceutical

πŸ“Š Get full analytics about Chugai Pharmaceutical

Sign up for free or log in

πŸ“₯ Get our free eBook now: "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

© 2024 - 2026 InsightfulValue.com. All rights reserved. Newsletter
Legal